Search Results

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development biotechnology

Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

She received her undergraduate degree in Biotechnology from KIIT University in India.

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

networking, mentorship, PhD resilience, COVID-19 challenges, and his aspiration to transition into biotechnology